Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 Cr in Series B funding (opens original article in a new tab)

Kiran Mazumdar-Shaw's Immuneel Therapeutics raised Rs 100 Cr in Series B funding to expand manufacturing, R&D, and international operations.

• Raised Rs 100 Cr in Series B funding
• Funding will expand manufacturing capacity
• Funding will support R&D and international expansion